🛡️ CVE-2022-45456 — agent

🟠 CVSS 7.5 — High ✅ No Known Exploit CWE-287 NVD
7.5
CVSS Score
0 Low4 Medium7 High9 Critical10

Description

Denial of service due to unauthenticated API endpoint. The following products are affected: Acronis Agent (Windows, macOS, Linux) before build 30161.

How this vulnerability can be exploited

This issue can be reached over the network, attack complexity is low, an attacker needs no privileges on the target. No user interaction is required. The scope is unchanged, so the impact stays within the vulnerable component. Rated impact: confidentiality none, integrity none, availability high.

Weakness class

CVE-2022-45456 is classified as CWE-287: Improper Authentication. The identity of the caller is not established correctly, so an attacker can act as another user.

Affected software

CVE-2022-45456 is recorded against 1 package.

  • agent (fixed in c22.08)

Timeline and source

Published on 26 April 2023 and last revised on 17 June 2026. No public exploit is currently recorded for this entry. Record sourced from NVD.

References

security-advisory.acronis.com
security-advisory.acronis.com

Details

Severity HIGH
CVSS Score 7.5
CVSS Vector CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CWE CWE-287
Public Exploit ✅ No
Source NVD
Published 2023-04-26
Updated 2026-08-11
Modified 2026-06-17
Fix URL N/A

Affected Packages

Software From version Fixed in
agent — c22.08

Similar Threats

Site Security Check

Is agent part of your stack?

CVE-2022-45456 is rated CVSS 7.5 High. BotEraser scans your installation against known CVE records and tells you whether this vulnerability applies to the versions you actually run.

Scan My Site Free →

No credit card required  ·  Results in minutes

ⓘ Data Notice: The information presented above has been compiled from publicly available internet sources. Boteraser aggregates this data solely for informational purposes and does not independently classify, evaluate, or endorse any findings about the vulnerabilities listed. The accuracy and completeness of this information is the sole responsibility of the original publishers. Boteraser and its operators accept no liability for any decisions made based on this data.

Browse related advisories

All advisoriesCVECVE 2022